PMN

ProMIS Neurosciences, Inc. PMN

PMN
ProMIS Neurosciences, Inc. SNSE
Sensei Biotherapeutics, Inc. GLTO
Galecto, Inc. CLRB
Cellectar Biosciences, Inc. GOVX
GeoVax Labs, Inc. MBRX
Moleculin Biotech, Inc. ATHA
Athira Pharma, Inc. PALI
Palisade Bio, Inc. CTXR
Citius Pharmaceuticals, Inc. THAR
Tharimmune, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode PMN SNSE GLTO CLRB GOVX MBRX ATHA PALI CTXR THAR
6M -14.82 % 49.29 % 354.28 % -43.47 % -29.85 % -39.93 % 56.54 % 156.45 % 39.00 % 174.78 %
YTD -50.31 % 32.77 % 104.82 % -48.92 % -75.94 % -71.19 % -32.55 % -6.99 % -64.18 % 54.15 %
1Y -53.24 % 47.04 % 73.48 % -91.86 % -71.72 % -78.11 % -16.44 % -51.27 % -85.13 % 63.73 %
3Y -91.98 % -53.17 % -74.34 % -92.17 % -95.32 % -96.56 % -89.40 % -97.69 % -95.08 % -98.72 %
5Y -92.05 % -96.38 % -96.89 % -98.65 % -98.74 % -99.30 % -97.96 % -99.94 % -94.75 % -99.76 %
10Y -88.64 % -96.38 % -96.89 % -99.99 % -98.65 % -99.93 % -97.83 % -100.00 % -99.70 % -99.76 %
Depuis le début -99.34 % -96.38 % -96.89 % -100.00 % -98.65 % -99.93 % -97.83 % -100.00 % -99.63 % -99.76 %

Dividende